Aspen Aerogels (NYSE: ASPN) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.11) by 81.82 percent. This is a 91.67 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $94.501 million which beat the analyst consensus estimate of $75.004 million by 26.00 percent. This is a 107.30 percent increase over sales of $45.586 million the same period last year.